Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based ChemotherapyMatthew D. Galsky, Joaquim Bellmunt, Noah M. Hahn et al.|Journal of Clinical Oncology|2011Cited by 686
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial CarcinomaAndrea B. Apolo, Jonathan E. Rosenberg, Parminder Singh et al.|New England Journal of Medicine|2024Cited by 145
Impact of Histological Variants on Clinical Outcomes of Patients with Upper Urinary Tract Urothelial CarcinomaMichael Rink, Shahrokh F. Shariat, Brian D. Robinson et al.|The Journal of Urology|2012Cited by 142
<i>CDKN2A</i> Alterations and Response to Immunotherapy in Solid TumorsElio Adib, David J. Kwiatkowski, Amin H. Nassar et al.|Clinical Cancer Research|2021Cited by 129
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H. Nassar, Alexander Gusev, Elio Adib et al.|Cancer Cell|2022Cited by 117